La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Virbac Gestione

Gestione criteri di controllo 4/4

Virbac's Il CEO è Habib Ramdani, nominato in Jun2016, e ha un mandato di 8.17 anni. la retribuzione annua totale è € 442.92K, composta da 55.3% di stipendio e 44.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.014% delle azioni della società, per un valore di € 415.88K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.5 anni e 3.7 anni.

Informazioni chiave

Habib Ramdani

Amministratore delegato

€442.9k

Compenso totale

Percentuale dello stipendio del CEO	55.3%
Mandato del CEO	8.3yrs
Proprietà del CEO	0.01%
Durata media del management	3.5yrs
Durata media del Consiglio di amministrazione	3.8yrs

Aggiornamenti recenti sulla gestione

Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Jun 15

Recent updates

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Mar 22

Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Jan 18

Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Dec 27

Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Oct 19

Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Sep 26

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Sep 05

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Jun 20

Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

May 31

Is Virbac (EPA:VIRP) Using Too Much Debt?

Apr 09

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Feb 28

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 25

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

Oct 14

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

Aug 07

These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Jun 26

Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

May 01

We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Mar 26

Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Jan 26

Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

Dec 28

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Oct 27

Is Virbac (EPA:VIRP) Using Too Much Debt?

Oct 12

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Sep 26

Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Jul 15

Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Jun 27

Is Virbac (EPA:VIRP) A Risky Investment?

May 27

Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)

Mar 24

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?

Mar 12

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Feb 22

Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?

Feb 03

Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?

Jan 05

Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?

Dec 18

Estimating The Fair Value Of Virbac SA (EPA:VIRP)

Dec 01

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Habib Ramdani rispetto agli utili di Virbac?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	n/a	n/a	€141m
Mar 31 2024	n/a	n/a	€131m
Dec 31 2023	€443k	€245k	€121m
Sep 30 2023	n/a	n/a	€120m
Jun 30 2023	n/a	n/a	€119m
Mar 31 2023	n/a	n/a	€121m
Dec 31 2022	€395k	€233k	€122m
Sep 30 2022	n/a	n/a	€120m
Jun 30 2022	n/a	n/a	€119m
Mar 31 2022	n/a	n/a	€116m
Dec 31 2021	€458k	€227k	€113m
Sep 30 2021	n/a	n/a	€137m
Jun 30 2021	n/a	n/a	€161m
Mar 31 2021	n/a	n/a	€148m
Dec 31 2020	€311k	€222k	€136m
Sep 30 2020	n/a	n/a	€104m
Jun 30 2020	n/a	n/a	€72m
Mar 31 2020	n/a	n/a	€62m
Dec 31 2019	€299k	€213k	€52m
Sep 30 2019	n/a	n/a	€43m
Jun 30 2019	n/a	n/a	€34m
Mar 31 2019	n/a	n/a	€27m
Dec 31 2018	€400k	€203k	€20m
Sep 30 2018	n/a	n/a	€8m
Jun 30 2018	n/a	n/a	-€4m
Mar 31 2018	n/a	n/a	-€3m
Dec 31 2017	€212k	€203k	-€3m

Compensazione vs Mercato: La retribuzione totale di Habib ($USD 490.99K ) è inferiore alla media delle aziende di dimensioni simili nel mercato French ($USD 2.15M ).

Compensazione vs guadagni: La retribuzione di Habib è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Habib Ramdani (48 yo)

8.3yrs

Mandato

€442,921

Compensazione

Mr. Habib Ramdani servesa s Interim CEO of Virbac SA from July 2024. He has been Chief Financial Officer at Virbac SA since June 30, 2016 and serves as its Deputy Chief Executive Officer since December 15,...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Habib Ramdani	Interim CEO & CFO	8.3yrs	€442.92k	0.014% € 470.4k
Marc Bistuer	Deputy CEO and Head of Compliance & Corporate Quality Assurance	1.7yrs	€396.22k	0.088% € 2.9m
Sandrine Brunel	Head of Corporate Communications	no data	Nessun dato	Nessun dato
Nathalie Pollet	Head of Global Marketing & Market Development	3.7yrs	Nessun dato	Nessun dato
Francesca Cortella	Head of Corporate Human Resources	9.7yrs	Nessun dato	Nessun dato
Sophie Favini	Head of Global Business Operations	2.7yrs	Nessun dato	Nessun dato
Bertrand Havrileck	Head of Corporate R&D	3.4yrs	Nessun dato	Nessun dato
André Mathieu	Head of Global Industrial Operations	no data	Nessun dato	Nessun dato
Manuela Rodríguez	Director of Financial Projects	no data	Nessun dato	Nessun dato

3.5yrs

Durata media

Gestione esperta: Il team dirigenziale di VIRP è considerato esperto (durata media dell'incarico 3.5 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Pierre Madelpuech	Vice Chairman of the Board of Directors	3.8yrs	€27.00k	0.0013% € 43.0k
Marie-Helene Dick-Madelpuech	Chairwoman of Board of Directors	3.8yrs	€137.00k	50.19% € 1.6b
Xavier Yon	Non-Voting Advisor	no data	€24.00k	Nessun dato
Olivier Charmeil	Independent Director	less than a year	Nessun dato	0.00012% € 3.9k
Philippe Gaston Capron	Member of Board of Directors	3.8yrs	€30.00k	0.0053% € 173.3k
Cyrille Petit	Independent Member of Board of Directors	3.8yrs	€27.00k	0.0031% € 101.8k
Solene Madelpuech	Members of the Board of Directors	3.8yrs	€27.00k	0.00012% € 3.9k
Sylvie Gueguen	Employee Representative Director	3.8yrs	Nessun dato	0.0016% € 54.2k
Rodolphe Durand	Non-Voting Advisor	no data	€24.00k	Nessun dato

3.8yrs

Durata media

60yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di VIRP sono considerati esperti (durata media dell'incarico 3.7 anni).

Virbac Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Virbac Sa Announces Chief Executive Officer Changes

Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Virbac SA, Annual General Meeting, Jun 21, 2021

Recent updates

Virbac SA Just Beat Revenue Estimates By 6.0%

Unpleasant Surprises Could Be In Store For Virbac SA's (EPA:VIRP) Shares

Virbac SA Revises Earnings Guidance for the Fiscal Year 2024

Virbac Sa Announces Chief Executive Officer Changes

Upcoming dividend of €1.32 per share

Why We Think Virbac SA's (EPA:VIRP) CEO Compensation Is Not Excessive At All

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Dividend of €1.32 announced

Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected

Full year 2023 earnings released: EPS: €14.40 (vs €14.43 in FY 2022)

Virbac SA (ENXTPA:VIRP) acquired Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591).

Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results

Full year 2023 earnings: EPS misses analyst expectations

Virbac SA (ENXTPA:VIRP) entered into a definitive agreement to acquire Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591) for an enterprise value of approximately €280 million.

Virbac SA Provides Earnings Guidance for the Year 2024

Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?

Now 21% undervalued

Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up

Virbac SA to Report Fiscal Year 2023 Results on Mar 19, 2024

Price target increased by 11% to €327

Investor sentiment improves as stock rises 15%

Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.

First half 2023 earnings released: EPS: €8.86 (vs €9.18 in 1H 2022)

Virbac SA Confirms Revenue Forecasts for the Year 2023

Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?

Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Upcoming dividend of €1.32 per share at 0.5% yield

Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?

Is Virbac (EPA:VIRP) Using Too Much Debt?

Full year 2022 earnings released: EPS: €14.44 (vs €13.40 in FY 2021)

Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?

Virbac SA to Report First Half, 2023 Results on Sep 14, 2023

Virbac SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate

Price target decreased to €341

Investor sentiment deteriorated over the past week

Price target decreased to €348

Virbac SA Provides Revenue Guidance for the Year 2022

Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: €9.18 (vs €8.54 in 1H 2021)

Investor sentiment deteriorated over the past week

An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued

These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely

Upcoming dividend of €1.25 per share

Full year 2021 earnings: EPS exceeds analyst expectations

Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate

We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease

Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate

Virbac SA Provides Revenue Guidance for the Year 2022

Price target increased to €435

Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock

Price target increased to €416

A Look At The Fair Value Of Virbac SA (EPA:VIRP)

Is Virbac (EPA:VIRP) Using Too Much Debt?

Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today

Investor sentiment improved over the past week

Price target increased to €367

Virbac SA (ENXTPA:VIRP) acquired an additional 15% stake in Centrovet group for $17.7 million.

Price target increased to €341

Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?

Consensus EPS estimates increase to €10.34

Price target increased to €305

Virbac SA Raises Revenue Guidance for 2021

Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?

Upcoming dividend of €0.75 per share

Is Virbac (EPA:VIRP) A Risky Investment?

Friulchem S.p.A. (BIT:FCM) signed a preliminary agreement to acquire Business Unit of Virbac SA (ENXTPA:VIRP) for €2.5 million.